Julia Hupfeld
Overview
Explore the profile of Julia Hupfeld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hupfeld J, Dolle M, Volk H, Rieder J
BMC Vet Res
. 2023 Sep;
19(1):152.
PMID: 37689678
Background: Canine hypoadrenocorticism is a rare chronic disease, which demands intense dog-owner interaction, as its treatment requires to be individualised. The aim of this study was a qualitative analysis of...
2.
Hupfeld J, Dolle M, Volk H, Rieder J
Vet Rec
. 2022 Aug;
191(10):e1977.
PMID: 35941756
Background: The treatment of canine adrenal insufficiency consists of hormone substitution and requires high owner compliance and intense human-dog interaction. This might affect the quality of life (QoL) of owners...
3.
Hupfeld J, Ernst M, Knyrim M, Binas S, Kloeckner U, Rabe S, et al.
Biomedicines
. 2021 Jul;
9(7).
PMID: 34201741
MicroRNAs (miRs) contribute to different aspects of cardiovascular pathology, among them cardiac hypertrophy and atrial fibrillation. Cardiac miR expression was analyzed in a mouse model with structural and electrical remodeling....
4.
Binas S, Knyrim M, Hupfeld J, Kloeckner U, Rabe S, Mildenberger S, et al.
Cell Mol Life Sci
. 2019 Jul;
77(5):903-918.
PMID: 31312877
MicroRNAs (miRs) contribute to different aspects of cardiovascular pathology, among others cardiac hypertrophy and atrial fibrillation. The aim of our study was to evaluate the impact of miR-221/222 on cardiac...
5.
Hupfeld J, Gorr I, Schwald C, Beaucamp N, Wiechmann K, Kuentzer K, et al.
Biotechnol Bioeng
. 2014 Jun;
111(11):2290-302.
PMID: 24890974
Mesenchymal stromal cells (MSCs) are promising candidates for cell therapy. Their therapeutic use requires extensive expansion to obtain a sufficiently high number of cells for clinical applications. State-of-the-art expansion systems,...
6.
Wegmeyer H, Broske A, Leddin M, Kuentzer K, Nisslbeck A, Hupfeld J, et al.
Stem Cells Dev
. 2013 May;
22(19):2606-18.
PMID: 23676112
Mesenchymal stromal cells (MSCs) are rare progenitor cells that can be isolated from various tissues. They exhibit multilineage differentiation potential, support regenerative processes, and interact with various immune cells. Therefore,...
7.
Hupfeld J, Efferth T
In Vivo
. 2009 Apr;
23(1):1-6.
PMID: 19368117
Acquired immune deficiency syndrome (AIDS) caused by infection with the human immunodeficiency virus (HIV) represents a major health problem worldwide, especially in developing countries. Combinational anti-HIV therapy has largely improved...
8.
Tapley T, Korner J, Barge M, Hupfeld J, Schauerte J, Gafni A, et al.
Proc Natl Acad Sci U S A
. 2009 Mar;
106(14):5557-62.
PMID: 19321422
HdeA has been shown to prevent acid-induced aggregation of proteins. With a mass of only 9.7 kDa, HdeA is one of the smallest chaperones known. Unlike other molecular chaperones, which...